Search Results - "receptor tyrosine kinase"

Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer by Vignesh Sivaganesh, Bela Peethambaran

Connect to this object online.

Design and green synthesis of novel quinolinone derivatives of potential anti-breast cancer activity against MCF-7 cell line targeting multi-receptor tyrosine kinases by Mohamed Mokhtar, Khadijah S. Alghamdi, Nesreen S. Ahmed, Dina Bakhotmah, Tamer S. Saleh

Connect to this object online.

Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer by Na Xiao MD, Hailang He MD, Jing Wang MD, Li Zhang MD, Brandon Chow, Fanchao Feng MD, Yong Xu MD, Jingyi Huang MD, Xianmei Zhou MD, Rui Dong MD

Connect to this object online.

Repurposing Synthetic Congeners of a Natural Product Aurone Unveils a Lead Antitumor Agent Inhibiting Folded P-Loop Conformation of MET Receptor Tyrosine Kinase by Ahmed H. E. Hassan, Cai Yi Wang, Cheol Jung Lee, Hye Rim Jeon, Yeonwoo Choi, Suyeon Moon, Chae Hyeon Lee, Yeon Ju Kim, Soo Bin Cho, Kazem Mahmoud, Selwan M. El-Sayed, Sang Kook Lee, Yong Sup Lee

Connect to this object online.

Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients by Park JE, Hong MJ, Lee SY, Lee JH, Choi JE, Kang HG, Do SK, Jeong JY, Shin KM, Lee WK, Choi SH, Lee YH, Seo HW, Yoo SS, Lee J, Cha SI, Kim CH, Park JY

Connect to this object online.

Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer by Na Xiao MD, Hailang He MD, Jing Wang MD, Li Zhang MD, Brandon Chow, Fanchao Feng MD, Yong Xu MD, Jingyi Huang MD, Xianmei Zhou MD, Rui Dong MD

Connect to this object online.

Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Alterations in Low-Grade Gliomas: Report of a Novel Gene Fusion Partner in a Pilocytic Astrocytoma and Review of the Literature by Siobhan S. Pattwell, Eric Q. Konnick, Yajuan J. Liu, Rebecca A. Yoda, Laligam N. Sekhar, Patrick J. Cimino

Connect to this object online.

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells by Wei Zhang, Wei Zhang, Ying-Fang Fan, Ying-Fang Fan, Chao-Yun Cai, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Leli Zeng, Leli Zeng, Pranav Gupta, Zhe-Sheng Chen

Connect to this object online.

Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis by Fanming Kong, Fanming Kong, Chaoran Wang, Chaoran Wang, Chaoran Wang, Xiaojiang Li, Xiaojiang Li, Yingjie Jia, Yingjie Jia

Connect to this object online.

Evaluation of factors affecting epidermal growth factor receptor tyrosine kinase inhibitor-induced hepatotoxicity in Japanese patients with non-small cell lung cancer: a two-center retrospective study by Hirofumi Nagai, Tsutomu Shimada, Yoshimitsu Takahashi, Mikako Nishikawa, Hiroyuki Tozuka, Yasuto Yamamoto, Osamu Niwa, Yutaka Takahara, Arimi Fujita, Katsuhiko Nagase, Kazuo Kasahara, Seiji Yano, Yoshimichi Sai

Connect to this object online.

CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in <i>Opisthorchis viverrini</i>-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS by Jinchutha Duangdara, Boonyakorn Boonsri, Apinya Sayinta, Kittiya Supradit, Pakpoom Thintharua, Supeecha Kumkate, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Somkit Mingphruedhi, Narongsak Rungsakulkij, Paramin Muangkaew, Pongsatorn Tangtawee, Watoo Vassanasiri, Wikran Suragul, Tavan Janvilisri, Rutaiwan Tohtong, David O. Bates, Kanokpan Wongprasert

Connect to this object online.

Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis by Mai Maher, Asmaa E. Kassab, Ashraf F. Zaher, Zeinab Mahmoud

Connect to this object online.

Compound 15c, a Novel Dual Inhibitor of EGFRL858R/T790M and FGFR1, Efficiently Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance of Non-Small-Cell Lung Cancers by Gaozhi Chen, Gaozhi Chen, Yuyan Bao, Qiaoyou Weng, Yingxin Zhao, Xiaoyao Lu, Lili Fu, Lingfeng Chen, Zhiguo Liu, Xiaomin Zhang, Guang Liang

Connect to this object online.

Comparative Pathology and Immunohistochemistry of Veterinary Species

Subjects: “…receptor tyrosine kinase (KIT)…”
DOAB: download the publication
DOAB: description of the publication

Virus-Host Cell Interactions

Subjects: “…Axl receptor tyrosine kinase…”
DOAB: download the publication
DOAB: description of the publication

Integrative Multi-Omics in Biomedical Research

Subjects: “…receptor tyrosine kinases…”
DOAB: download the publication
DOAB: description of the publication

Precision Medicine in Solid Tumors

Subjects: “…anaplastic lymphoma receptor tyrosine kinase…”
DOAB: download the publication
DOAB: description of the publication

10th Anniversary of Cells&mdash;Advances in Cell Cycle

Subjects: “…receptor tyrosine kinases…”
DOAB: download the publication
DOAB: description of the publication

Anticancer Inhibitors

Subjects: “…receptor tyrosine kinases…”
DOAB: download the publication
DOAB: description of the publication

Integrating Clinical and Translational Research Networks-Building Team Medicine

Subjects: “…receptor tyrosine kinases…”
DOAB: download the publication
DOAB: description of the publication